Glympse Bio, Inc. Secures $22 Million Series A Financing
October 10, 2018
2:09 pm
Bioengineering startup Glympse Bio, Inc., raised $22 million in a Series A funding round co-led by venture capital firms LS Polaris Innovation Fund and ARCH Ventures. In addition, new investors Charles River Ventures, Gilead Sciences, Yonghua Capital, and Inevitable Ventures were joined by existing investors